-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

322. Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological: Poster II Clinically Relevant Abstract

Symposia: Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 11, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Jabra Zarka1*, Kwonho Jeong, MS2*, Jonathan G. Yabes, PhD2* and Margaret V. Ragni, MD, MPH3

1University of Pittsburgh Medical Center, Pittsburgh, PA
2Center for Research on Health Care Data Center, Department of Medicine University of Pittsburgh, Pittsburgh, PA
3Department of Medicine, University of Pittsburgh, Pittsburgh, PA

Edward Tuddenham, MD1*, Gavin Ling, PhD, MBBS, FRCPath2 and Richard Wolf-Garraway, PhD3*

1Department of Haematology, UCL Cancer Institute, London, United Kingdom
2Haematology Department, UCL Cancer Institute, London, United Kingdom
3Ascension Healthcare plc, London, United Kingdom

Caroline Malcolmson, MD1, Michael Shu1*, Vanessa Bouskill, MN, NP2*, Ann Marie Stain, RN2*, Cindy Wakefield, RN2*, Victor Blanchette, MD, FRCP, FRCPC1 and Manuel Carcao, MD, MSc1

1Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada
2Department of Nursing, The Hospital for Sick Children, Toronto, ON, Canada

Kingsley Hampton1*, Paul Knoebl, MD2*, Jan Odgaard-Jensen3*, Oleksandra Stasyshyn, MD, PhD4*, Jay Jay Thaung Zaw3*, Jesper Skov Neergaard3* and Bulent Zulfikar, Prof5*

1Department of Cardiovascular Science, University of Sheffield, Sheffield, ENG, United Kingdom
2Department of Medicine 1, Division of Hematology and Hemostasis, Medical University of Vienna, Vienna, Austria
3Novo Nordisk A/S, Søborg, Denmark
4Academy of Medical Sciences of Ukraine, Lviv, Ukraine
5Department of Pediatric Hematology/Oncology, Istanbul University Oncology Institute, ISTANBUL, Turkey

Maria E Carter Febres, MD1,2*, Matthew E Fenchel1*, Jennifer Pomales, RN, BSN, NE-BC, CPHON3*, Cristina Tarango, MD4,5 and Eric S. Mullins, MD2,3

1Cincinnati Children’s Hospital Medical Center, Cancer and Blood Diseases Institute, Cincinnati, OH
2Division of Hematology, Cancer and Blood Diseases Institute, University of Cincinnati College of Medicine, Cincinnati
3Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
4Cancer and Blood Diseases Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
5Division of Hematology, Cancer and Blood Diseases Institute, University of Cincinnati College of Medicine, Cincinnati, OH

Amanda Wilson, MPH, PhD1*, Nana Kragh2*, Jennifer Dumont, PhD3, Jerome Msihid, MSc4*, Annemieke Willemze, MD, PhD5*, Linda Bystricka6,7*, Chuanwu Zhang3*, Angela C. Weyand, MD8, Kathelijn Fischer, MD9* and Victor Jimenez-Yuste10*

1Sanofi, Cambridge, USA, Cambridge, MA
2Sobi (Swedish Orphan Biovitrum AB ), Stockholm, Sweden
3Sanofi, Cambridge, MA
4Sanofi, Chilly-Mazarin, France
5Sanofi, Amsterdam, Netherlands
6SOBI (Swedish Orphan Biovitrum AB), Stockholm, Sweden
7Swedish Orphan Biovitrum AB, Stockholm, Sweden
8University of Michigan, Ann Arbor, MI
9Van Creveldkliniek, Center for Benign Hematology, Thrombosis and Haemostasis, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
10Autónoma University Madrid and La Paz University Hospital, Madrid, Spain

Mark T Reding, MD1, Maria Elisa Mancuso, MD, PhD2*, Suchitra Acharya, MD, MBBS3, Sanjay Ahuja, MD4, Maria Teresa Álvarez-Román, MD5*, Lisa N Boggio, MD, MS6, Meera B. Chitlur, MD7, Abraham Salvador Majluf-Cruz, MD8*, Amy L Dunn, MD9*, Miguel Escobar, MD10*, Annie Harroche, MD11*, Maissaa Janbain, MD12, Craig M. Kessler, MD13, Philip Maes, MD14*, Catherine E. McGuinn, MD15, Danielle Nance, MD16, Ulrike Nowak-Göttl, MD, PhD17*, Robert F. Sidonio, Jr., MD, MSc18, Duc Q Tran Jr., MD, MSc19, Michael Wang, MD20, Jerzy Windyga, MD, PhD21*, Hongying Wang, MS22*, Thomas Wilkinson, PhD23* and Steven W. Pipe, MD24

1Center for Bleeding and Clotting Disorders, University of Minnesota Medical Center, Minneapolis, MN
2Center for Thrombosis and Haemorrhagic Diseases, IRCCS Humanitas Research Hospital, Milan, Italy
3Cohen Children's Medical Center, Northwell Hemostasis and Thrombosis Center, Northwell Health, New Hyde Park, NY
4Division of Pediatric Hematology & Oncology, Rainbow Babies and Children's Hospital, Cleveland, OH
5Department of Hematology and Hemotherapy, Hospital Universitario La Paz, Autónoma University, Madrid, Spain
6Rush Hemophilia & Thrombophilia Center, Rush University Medical Center, Chicago, IL
7Central Michigan University College of Medicine/ Children's Hospital of Michigan, Carmen and Ann Adams Department of Pediatrics, Division of Hematology/Oncology, Detroit, MI
8Unidad de Investigacion Medica en Trombosis, Hemostasia y Aterogenesis, Instituto Mexicano del Seguro Social, Mexico City, Mexico
9Nationwide Children's Hospital, Columbus, OH
10University of Texas Health Science Center, Houston, TX
11Hemophilia Care Centre, Hematology Unit, Hôpital Universitaire Necker enfants malades, Paris, France
12Tulane University Health Sciences Center, New Orleans, LA
13Georgetown University Medical Centre, Washington, DC
14Paediatric Haematology and Oncology Department, University Hospital of Antwerp, Antwerp, Belgium
15Department of Pediatrics, Division of Pediatric Hematology Oncology, Weill Cornell Medicine, New York, NY
16Banner MD Anderson Cancer Center, Gilbert, AZ
17Institute of Clinical Chemistry, Thrombosis and Haemostasis Treatment Centre, University Hospital, Kiel-Lübeck, Germany
18Aflac Cancer and Blood Disorders, Department of Pediatrics, Emory University School of Medicine, Decatur, GA
19Department of Hematology and Medical Oncology, Hemophilia of Georgia Center for Bleeding & Clotting Disorders of Emory, Emory University School of Medicine, ATLANTA, GA
20Hemophilia and Thrombosis Center, University of Colorado Anschutz Medical Campus, Aurora, CO
21Department of Hemostasis Disorders and Internal Medicine, Laboratory of Hemostasis and Metabolic Diseases, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
22LFB-USA, Inc., Framingham, MA
23GLOVAL LLC, Monterey Park, CA
24University of Michigan, Ann Arbor, MI

Angela C. Weyand, MD1, Martin Chandler, BS2*, Carol Fedor, RN2*, Michael Recht, MD, PhD, MBA2 and Robert F. Sidonio, Jr., MD, MSc3

1University of Michigan, Ann Arbor, MI
2American Thrombosis and Hemostasis Network, Rochester, NY
3Aflac Cancer and Blood Disorders Center, Emory University, Decatur, GA

Yun Gu1*, Kui Huang, PhD, MPH2*, Xunming Sun, PhD, MS1*, Xiaofeng Zhou, PhD, MS2*, Rongjun Shen, MS2*, Lisa J. Young, MSc, CMD3*, Amit Chhabra, MBBS, MPH2, Gregory Di Russo, MD, FACS1*, Jeremy Rupon, MD, PhD1 and Ian Winburn, MBBS, PhD, MRCS3*

1Pfizer Inc., Collegeville, PA
2Pfizer Inc., New York, NY
3Pfizer Ltd, Walton on the Hill, Surrey, United Kingdom

Chanchala Kaddi1*, Mengdi Tao, MS1*, Randolph Leiser, PhD1*, Ane Salvador, PhD2*, Sravya Kattula, PhD2*, Pratik Bhagunde3*, Viridiana Cano Garcia, MD4, Ekta Seth Chhabra, PhD2* and Susana Zaph, PhD1*

1Translational Disease Modelling, Data and Data Science, Sanofi, Cambridge, MA
2Rare and Neurologic Diseases, Sanofi, Cambridge, MA
3Sanofi, Bridgewater, NJ
4Sanofi, Cambridge, MA

Kanak Parmar, MBBS1, Shivam Singh2*, Lukman Tijani, MD3* and David A. Garcia, MD4

1Texas Tech University Health Sciences Center, Lubbock, TX
2King Gorge Medical University, Lucknow, India
3Hematology Oncology Department, Texas Tech University Health Science Center, Lubbock, TX
4Division of Hematology, University of Washington School of Medicine, Seattle, WA

Amanda Wilson, MPH, PhD1*, Nana Kragh2*, Jerome Msihid, MSc3*, Jennifer Dumont, PhD4, Annemieke Willemze, MD, PhD5*, Elena Santagostino, MD, PhD6, Chuanwu Zhang4*, Roshni Kulkarni, MD7, Annette von Drygalski, MD, Pharm D8 and Pratima Chowdary, MBBS, MRCP, FRCPATH9*

1Sanofi, Cambridge, USA, Cambridge, MA
2Sobi (Swedish Orphan Biovitrum AB ), Stockholm, Sweden
3Sanofi, Chilly-Mazarin, France
4Sanofi, Cambridge, MA
5Sanofi, Amsterdam, Netherlands
6Swedish Orphan Biovitrum AG, Basel, Switzerland
7Department of Pediatrics and Human Development, Michigan State University, East Lansing, MI
8Department of Medicine, Division of Hematology/Oncology, University of California San Diego, San Diego, CA
9Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London, England, London, United Kingdom

Mark T Reding, MD1, María Teresa Alvarez Román, MD, PhD2*, Martin Sanabria3*, Giancarlo Castaman, MD4*, Maissaa Janbain5, Tadashi Matsushita, MD, PhD6, Karina Meijer, MD, PhD7, Kathrin Schmidt8* and Johannes Oldenburg9

1University of Minnesota Medical Center, Minneapolis, MN
2Hospital Universitario La Paz, Madrid, Spain
3Bayer, Basel, Switzerland
4Careggi University Hospital, Florence, Italy
5Tulane School of Medicine, New Orleans, LA
6Nagoya University Hospital, Nagoya, Japan
7University Medical Center Groningen, Groningen, Netherlands
8Bayer, Berlin, Germany
9Institute for Experimental Hematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany

Zhengping Li, MBBS1*, Guoqing Liu2*, Zhen Yingzi3*, Xiaoling Cheng4*, Zhenping Chen, PhD, MD5,6,7*, Di Ai3*, Zekun Li, MD3,8*, Jie Sun3*, Kun Huang Sr.3* and Runhui Wu, MD, PhD9*

1Hematology Department, Beijing Children's Hospital, Capital Medical University, Beijing, AL, China
2Hemophilia Comprehensive Care Center, Beijing Children's Hospital, Capital Medical University, Beijing, China
3Beijing Children's Hospital, Capital Medical University, Beijing, China
4Beijing Children’s Hospital, Capital Medical University, Beijing, China
5Beijing Children's Hospital, Beijing, CHN
6Hemophilia Comprehensive Care Center, Beijing Children’s Hospital, Capital Medical University, Beijing, China
7Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, Beijing, China
8Beijing Children's hospital, Capital Medical University, Beijing, China
9Department of Hematology, National Center for Children's Health, Beijing Children's Hospital, Beijing, China

Edward Tuddenham, MD1*, Richard Wolf-Garraway, PhD2* and Gavin Ling, PhD, MBBS, FRCPath3

1Department of Haematology, UCL Cancer Institute, London, United Kingdom
2Ascension Healthcare plc, London, United Kingdom
3Haematology Department, UCL Cancer Institute, London, United Kingdom

Meera B. Chitlur, MD

Central Michigan University College of Medicine/ Children's Hospital of Michigan, Carmen and Ann Adams Department of Pediatrics, Division of Hematology/Oncology, Detroit, MI

Jerzy Windyga, MD, PhD1*, Joanna Zdziarska, MD, PhD2*, Ewa Stefanska-Windyga, MD, PhD3*, Ewa Chmielewska, MD4*, Krzysztof Chojnowski, MD, PhD5*, Michal Jamrozik, MD6*, Aleksandra Kostyra, MD7*, Justyna Kozinska, MD, PhD8*, Halyna Krainiak, MD9*, Jolanta Oleksiuk, MD, PhD10*, Joanna Rupa-Matysek, MD, PhD11, Ewa Zarzycka, MD12* and Anna Buczma, MD, PhD1*

1Department of Hemostasis Disorders and Internal Medicine, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
2Department of Hematology, Jagiellonian University Medical College, Cracow, Poland
3Outpatient Clinic for Persons with Disorders of Hemostasis, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
4Department of Hematology, Pomeranian Medical University, Szczecin, Poland
5Institute of Hemostasis, Department of Hematology, Medical University of Lodz, Lodz, Poland
6Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland
7Department of Hematology, Nicolaus Copernicus Hospital, Torun, Poland
8Department and Clinic of Hemato-oncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland
9Outpatient Clinic of Hematology Multi-specialist Hospital in Gorzow Wielkopolski, Gorzow Wielkopolski, Poland
10Department of Hematology, Medical University of Bialystok, Bialystok, Poland
11Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland
12Department of Hematology and Transplantology, Medical University, Gdansk, Poland

Jung Woo Han, MD1*, Hee Jo Baek, MD, PhD2*, Young Shil Park, MD, PhD3*, Sangkyu Park, MD4*, Ki Young Yoo, MD5*, Eun Jin Choi, MD6*, JI Yoon KIM, MD7*, Won Kee Ahn, MD8*, Seungmin Hahn, MD9*, Chuhl Joo Lyu, MD, PhD10* and Soon Ki Kim, MD11*

1Department of Pediatric Hemato-Oncology, Yonsei Cancer Center, Yonsei University Health System, Seoul, Korea, Republic of (South)
2Department of Pediatrics, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun--Gun, Korea, Republic of (South)
3Department of Pediatrics, Kyung Hee University School of Medicine, Seoul, Korea, Republic of (South)
4Pediatrics, Ulsan University Hospital, Ulsan, KOR
5Seoul Clinic, Korean Hemophilia Foundation, Seoul, Korea, Republic of (South)
6Pediatrics, Daegu Catholic University Medical Center, Daegu, Korea, Republic of (South)
7Department of Pediatrics, Kyungpook National University School of Medicine, Korea, Daegu, Korea, Republic of (South)
8Department of Pediartic Hematology and Oncology, Yonsei Cancer Center, Yonsei University Health System, Seoul, Korea, Republic of (South)
9Department of Pediatrics, Yonsei University College of Medicine, Seoul, South Korea
10Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea, Republic of (South)
11Department of Pediatrics, College of Medicine, Inha University, Korea, Incheon, AP, KOR

Sylvia Werner1* and Sigurd Knaub, M.D.2

1Octapharma USA, Paramus, NJ
2Octapharma AG, Lachen, Switzerland

Yoshiyuki Ogawa, MD1*, Kagehiro Amano, MD2, Akiko Ioka, BS3*, Daisuke Nosaka, BS3*, Yoichi Murakami, BS3*, Hiroki Adachi, MS3* and Keiji Nogami, MD4*

1Gunma University Hospital, Maebashi, Japan
2Tokyo Medical University, Tokyo, Japan
3Chugai Pharmaceutical Co., Ltd., Tokyo, Japan
4Nara Medical University, Nara, Japan

Qu Cuiyun, MD1*, Wei Liu2*, Lingling Chen, BS1*, Lei Zhang, MD1*, Feng Xue, MD1* and Renchi Yang, MD3

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
3Institute of Hematology & Blood Disease, Tianjin, China

Stephanie Valer Seremetis, MD1, Wan Hui Ong Clausen, PhD2*, Irina Matytsina3*, Susanne Møller Nissen, MSc, PharmD3* and Karin Wåhlander, MD, PhD3*

1Rare Disease, Novo Nordisk Inc, Plainsboro, NJ
2Statistics, Novo Nordisk A/S, Søborg, Denmark
3Rare Disease & Advanced Therapies, Novo Nordisk A/S, Søborg, Denmark

Nasir Sadeghi1*, Fakiha Siddiqui, BS1,2, Emily Krupa, BS2*, Debra Hoppensteadt, PhD2*, Bulent Kantarcioglu, MD2, Massimo Lacobelli3* and Jawed Fareed, PhD4

1Loyola University Chicago, Maywood, IL
2Department Of Pathology And Laboratory Medicine, Cardiovascular Research Institute, Health Sciences Division, Loyola University Chicago, Maywood, IL
3Techitra s.r.l., Milan, Italy
4Department of Molecular Pharmacology & Neuroscience, Loyola University Medical Center, Maywood, IL

Laura Villarreal Martinez, MD1*, Katarina Cepo, MD2*, Jannie Laursen2*, Jan Odgaard-Jensen3*, Chur-Woo You, MD, PhD4* and Jerzy Windyga, MD, PHD5*

1Dr. José Eleuterio González Monterrey University Hospital, Monterrey, NL, Mexico
2Rare Disease Medical & Science, Novo Nordisk A/S, Søborg, Denmark
3Biostatistics RD & AT1, Novo Nordisk A/S, Søborg, Denmark
4Department of Pediatrics, Daejeon Eulji Medical Center, Eulji University School of Medicine, Daejeon, Korea, Republic of (South)
5Laboratory of Hemostasis and Metabolic Diseases, Department of Hemostasis Disorders and Internal Medicine, Institute of Hematology and Transfusion Medicine, Warsaw, Poland

Ang Li, MD, MS1, Jennifer La, PhD2*, Sarah B May, MS, MPH3*, Danielle Guffey4*, Wilson L Da Costa Jr., MD MPH PhD5*, Christopher I Amos6*, Emily Milner7*, Raka Bandyo8*, Carolina Granada1*, Nimrah Riaz, MS7*, Nhan V Do, MD9*, Mary Brophy, MD, MPH10*, Vipul Chitalia, MD11*, J. Michael Gaziano, MD, MPH12*, David A. Garcia, MD13, Marc Carrier, MD, MSc14, Christopher R. Flowers, MD15, Neil Zakai, MD16* and Nathanael Fillmore17*

1Hematology-Oncology, Baylor College of Medicine, Houston, TX
2Department of Medicine, VA Boston Healthcare System, Boston, MA
3Baylor College of Medicine, Houston, TX
4Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX
5Division of Epidemiology and Population Science, Baylor College of Medicine, Houston, TX
6Epidemiology and Population Sciences, Baylor College of Medicine, Houston, TX
7Baylor College of Medicine, Houston
8Harris Health System, Houston, TX
9Boston University School of Medicine, Boston, MA
10Department of Medicine, Section of Hematology and Medical Oncology, Boston University School of Medicine, Boston Medical Center, Boston, MA
11VA Boston Healthcare System, Boston
12VA Boston Healthcare System, Boston, MA
13Division of Hematology, University of Washington, Seattle, WA
14Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada
15Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
16Larner College of Medicine at the University of Vermont, Burlington, VT
17VA Boston Healthcare System, Harvard Medical School, Jamaica Plain, MA

*signifies non-member of ASH